Clinical Trial Update: A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imatinib 400 mg daily in combination with methotrexate for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Gleevec (Imatinib)
• Rheumatrex (methotrexate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED